Immunoproliferative small intestinal disease (IPSID): the Indian scenario.
作者信息
Dhir V, Mohandas K M
出版信息
Indian J Gastroenterol. 1997 Jan;16(1):38.
PMID:9167388
Abstract
摘要
相似文献
1
Immunoproliferative small intestinal disease (IPSID): the Indian scenario.
Indian J Gastroenterol. 1997 Jan;16(1):38.
2
Immunoproliferative small intestinal disease.
Am J Gastroenterol. 2000 Mar;95(3):848. doi: 10.1111/j.1572-0241.2000.01877.x.
3
[Immunoproliferative small intestinal disease (IPSID): IPSID-like lymphomas, IPSID equivalents?, in 12 Spanish patients].
Sangre (Barc). 1995 Dec;40(6):485-9.
4
Immunoproliferative small intestinal disease: a frequently missed diagnosis.
Indian J Gastroenterol. 1996 Apr;15(2):46-8.
5
Is immunoproliferative small intestinal disease uncommon in India?
Trop Gastroenterol. 2001 Jan-Mar;22(1):14-7.
6
The Evolution of Our Understanding of Immunoproliferative Small Intestinal Disease (IPSID) over Time.
Curr Oncol. 2022 May 23;29(5):3759-3769. doi: 10.3390/curroncol29050301.
7
Immunoproliferative Small Intestinal Disease Diagnosed by Double-balloon Endoscopy with Biopsy Sampling.
Intern Med. 2022 Sep 1;61(17):2593-2599. doi: 10.2169/internalmedicine.8847-21. Epub 2022 Feb 8.
8
Roles of syndecan-1, bcl6 and p53 in diagnosis and prognostication of immunoproliferative small intestinal disease.
World J Gastroenterol. 2006 Jun 14;12(22):3602-8. doi: 10.3748/wjg.v12.i22.3602.
9
Immunoproliferative small intestinal disease presented with ascites and edema.
Acta Clin Croat. 2013 Sep;52(3):387-90.
10
[Immunoproliferative disease of the small intestine. A rare differential diagnosis of Crohn's disease].
Dtsch Med Wochenschr. 1991 Aug 23;116(34):1265-9. doi: 10.1055/s-2008-1063745.
引用本文的文献
1
Roles of syndecan-1, bcl6 and p53 in diagnosis and prognostication of immunoproliferative small intestinal disease.
World J Gastroenterol. 2006 Jun 14;12(22):3602-8. doi: 10.3748/wjg.v12.i22.3602.
Zotero 插件